TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
BioInvent International AB
Closing information (x1000 DKK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
29,022
|
47,999
|
217,928 |
| Financial expenses |
421
|
1,026
|
531 |
| Earnings before taxes |
-278,773
|
-221,720
|
-28,402 |
| EBITDA |
-305,933
|
-248,481
|
-34,027 |
| Total assets |
642,467
|
940,465
|
1,144,158 |
| Current assets |
612,578
|
761,185
|
724,406 |
| Current liabilities |
61,832
|
50,992
|
58,349 |
| Equity capital |
575,300
|
879,710
|
1,073,264 |
| - share capital |
8,548
|
8,840
|
8,683 |
| Employees (average) |
112
|
104
|
89 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
89.5%
|
93.5%
|
93.8% |
| Turnover per employee |
259
|
462
|
2,449 |
| Profit as a percentage of turnover |
-960.6%
|
-461.9%
|
-13.0% |
| Return on assets (ROA) |
-43.3%
|
-23.5%
|
-2.4% |
| Current ratio |
990.7%
|
1492.8%
|
1241.5% |
| Return on equity (ROE) |
-48.5%
|
-25.2%
|
-2.6% |
| Change turnover |
-17,389
|
-171,052
|
204,975 |
| Change turnover % |
-37%
|
-78%
|
1582% |
| Chg. No. of employees |
8
|
15
|
10 |
| Chg. No. of employees % |
8%
|
17%
|
13% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.